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Abstract
Endoplasmic reticulum (ER) stress induces a complex network of pathways collectively termed the unfolded protein
response (UPR). The clarification of these pathways has linked the UPR to the regulation of several physiological processes.
However, its crosstalk with cellular iron metabolism remains unclear, which prompted us to examine whether an UPR affects
the expression of relevant iron-related genes. For that purpose, the HepG2 cell line was used as model and the UPR was
activated by dithiothreitol (DTT) and homocysteine (Hcys). Here, we report that hepcidin, a liver secreted hormone that
shepherds iron homeostasis, exhibits a biphasic pattern of expression following UPR activation: its levels decreased in an
early stage and increased with the maintenance of the stress response. Furthermore, we show that immediately after
stressing the ER, the stress-inducible transcription factor CHOP depletes C/EBPa protein pool, which may in turn impact on
the activation of hepcidin transcription. In the later period of the UPR, CHOP levels decreased progressively, enhancing C/
EBPa-binding to the hepcidin promoter. In addition, analysis of ferroportin and ferritin H revealed that the transcript levels
of these iron-genes are increased by the UPR signaling pathways. Taken together, our findings suggest that the UPR can
have a broad impact on the maintenance of cellular iron homeostasis.
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Introduction
The endoplasmic reticulum (ER) has evolved a high degree of
plasticity, allowing the adjustment of its environment according to the
transit of client proteins. The organelle homeostasis, however, can be
threatened by numerous stimuliwhich overall contribute to the luminal
accumulation of improperly folded proteins [reviewed in 1]. Aiming at
relieving such stressful condition, a finely coordinated signaling
program known as Unfolded Protein Response (UPR) is elicited [1].
Its mechanisms of action can be summarized as follows: global
repression of protein synthesis; induction of ER chaperones and
foldases to meet the increased folding demands and enhancement of
ER-associated degradation (ERAD) of irreversibly unfolded proteins
[1,2]. The UPR employs three ER-resident transmembrane proteins
that operate as proximal sensors and define independent signaling
pathways towards the cytosol/nucleus: PERK (double-stranded RNA-
dependent protein kinase-like ER kinase), IRE1 (inositol-requiring
enzyme 1) and ATF6 (activating transcription factor 6). The output of
these cascades entails the selective activation of transcription factors
whose main gene targets code for components of the ER protein-
processing machinery [3]. Prominent among this category is
immunoglobulin heavy chain-binding protein (BiP), an ER chaperone
with key sentinel activity [4].
The scope of the UPR-derived transcriptional signals goes
beyond the classical targets. A paradigmatic example is cyclic
AMP-responsive element binding protein H (CREBH) which,
albeit activated along the UPR, executes its transcriptional activity
over genes encoding inflammatory proteins [5]. Likewise, the
circulating iron-transport protein transferrin (TF) was identified as
a downstream target of CCAAT/enhancer-binding protein (C/
EBP) homologous protein (CHOP) [6], a stress-inducible tran-
scription factor. CHOP belongs to the C/EBP family and can
heterodimerize with other members of the same class [7]. Acting
as dominant negative inhibitor of other C/EBP isoforms, namely
C/EBPa, CHOP was reported to down-modulate TF gene
expression [6]. Interestingly, C/EBPa has also been described as
transcriptional activator of hepcidin [8]. Although not formally
tested, an identical mechanism to that depicted for TF was
proposed to justify the impaired hepcidin transcription observed in
two models of hepatic iron overload, induced by either hepatitis C
virus [9] or alcohol [10].
As a major orchestrator of iron homeostasis [11], hepcidin binds
to the iron exporter ferroportin and negatively regulates cellular
iron release into circulation [12]. A poor induction of hepcidin
despite the systemic iron overload has been found in Hereditary
Hemochromatosis (HH) [13]. The leading cause of this disorder –
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6618the C282Y mutation of HFE protein [14] – was recently coupled
to the activation of an UPR [15], which reinforces the interest of
exploring the UPR signaling/iron metabolism interplay.
To clarify this putative interconnection, we examined whether
activation of an UPR affects the expression of relevant iron-related
genes. Being the cellular ‘‘factory of iron-proteins’’ [reviewed in
16], hepatocytes emerged as the most relevant platform for our
study, herein recapitulated by the well-characterized human
hepatoma HepG2 cell line. Dithiothreitol (DTT) and homocyste-
ine (Hcys) were used as UPR inducers. Both agents interfere with
disulphide bond formation, thereby burdening the ER lumen with
misfolded proteins [17,18,19]. Using this approach, we show that
the gene profiles of hepcidin, ferroportin and ferritin H are
modulated throughout an active UPR. In addition, evidence
supporting the involvement of C/EBPa and CHOP on the
expression pattern exhibited by hepcidin is also provided.
Results
Experimental model of ER stress
Dose-response assays. The first part of the work was
assigned to establish the minimum concentration of stressor agent
able to robustly trigger an UPR. For this purpose, HepG2 cells
were exposed for 6 h to increasing doses of DTT and Hcys,
ranging from 0.5 to 10 mM and from 1 to 25 mM, respectively.
The mRNA and/or protein levels of the ER-resident chaperones
glucose regulated protein 94 (GRP94) and BiP, and of the stress-
inducible transcription factor CHOP were examined as markers of
UPR activation. Albeit with different magnitudes, both DTT and
Hcys elicited a dose-dependent up-regulation of GRP94, BiP and
CHOP, noticeable in terms of gene and protein expression (Fig. 1A
and B). Of note, CHOP transcript levels were very low in basal
conditions (Fig. 1A) and the respective protein was only detectable
after treatment with the highest concentrations tested
(DTT$2 mM and Hcys$5 mM; Fig. 1B). Since 2 mM DTT
and 10 mM Hcys were enough to ensure a fully-activated UPR,
distinguished by the simultaneous induction of BiP and CHOP,
they were chosen as working concentrations for the time-course
assays.
Time-course assays. In response to DTT, BiP and CHOP
exhibited markedly different expression profiles within the 24 h
time-frame analyzed. BiP transcripts increased consistently
throughout the experiment, only declining in the final period of
treatment, which is likely a consequence of the DTT labile
properties (Fig. 1C). At the protein level, however, a persistent up-
regulation of BiP was found at 24 h (Fig. 1D). Conversely, CHOP
transcripts manifested a strong induction after 2 h of DTT
incubation, rapidly abolished over time (Fig. 1C, black bars). This
pattern of CHOP expression was further confirmed by the
immunoblot results showing a protein peak at 5 h (Fig. 1D). Using
Hcys as ER-stressor, BiP and CHOP mRNA levels were both
gradually up-regulated over the 24 h treatment of HepG2 cells
(Fig. 1C). Extending the temporal window of the assay, we
observed a decline in the transcript abundance of these UPR
Figure 1. Monitoring of UPR activation markers in HepG2 cells during the DTT- and Hcys-induced ER-stress. Dose-response assays (A
and B): HepG2 cells were incubated for 6 h with increasing concentrations of DTT or Hcys, as indicated. Control cells received vehicle alone. Time-
course assays (C and D): HepG2 cells were exposed to 2 mM DTT or 10 mM Hcys for the indicated times. Control cells were left untreated. A and C,
BiP and CHOP mRNA levels were assessed by real-time RT-PCR and normalized to GAPDH expression. Results are expressed as fold change over
control-treated cells and represent the average+SD of three independent experiments. B and D, GRP94, BiP (using an anti-KDEL antibody) and CHOP
were measured by western blot in whole cell lysates of HepG2 cells. As loading control, membranes were stripped and reprobed for b-actin.
Representative blots of three independent experiments are shown. *p,0.05, **p,0.01, ***p,0.001 vs control.
doi:10.1371/journal.pone.0006618.g001
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expression was not mirrored by the protein profiles, however. As
Fig. 1D illustrates, whereas BiP increased from 12 to 48 h of Hcys
exposure, induction of CHOP protein became detectable at 5 h
and persisted until 36 h of incubation.
Expression of iron-related genes is modulated in the
context of an active UPR
To ascertain whether triggering of an UPR had an impact on
cellular iron metabolism, gene expression profiling of hepcidin,
ferritin H and ferroportin was performed on HepG2 cells. The
choice of these genes was based on their well documented roles in
iron homeostasis [reviewed in 20].
Upon 5 h of DTT treatment, the expression levels of hepcidin
in HepG2 cells were significantly reduced to approximately one-
half the control values, which was followed by a 10-fold up-
regulation at 24 h (Fig. 2A). Nearly identical effects were produced
when Hcys was used as stressor agent, although with less
pronounced increase (2-fold) of hepcidin trancripts in the late
stage of treatment (Fig. 2B). Ferroportin and ferritin H displayed
analogous expression patterns in the presence of 2 mM DTT and
10 mM Hcys, with both mRNAs being induced in a time-
dependent manner (Fig. 2A and B).
To gain additional insight into the modulation of the iron-genes
under scrutiny, we assessed the influence of varying doses of each
UPR inducer on their transcript levels. As Fig. 2C depicts,
hepcidin mRNA showed a biphasic pattern of expression in
response to DTT. Indeed, low concentrations of this stressor (0.5
and 1 mM) significantly increased hepcidin transcript levels,
whereas higher doses counteracted this effect. Unlike DTT, the
up-regulation of hepcidin mRNA was not evident when cells were
cultured in the presence of low concentrations of Hcys. However,
the down-modulation associated with higher doses of stress was
maintained (Fig. 2D). Concerning the other iron-related genes,
both ferroportin and ferritin H mRNAs reached a peak with
2 mM DTT, decreasing thereafter. Equivalent outcome was found
in Hcys treatments, with ferroportin and ferritin H increasing in a
dose-dependent fashion until 5 and 10 mM of stressor agent,
respectively.
Expression levels of albumin, herein employed as control gene,
were examined on cells exposed to DTT, with no differences
detected in either time- or dose-dependent assays (Fig. 2A and C).
Modulation of hepcidin expression upon DTT-elicited
UPR is chelatable iron-independent
The central role of hepcidin in iron homeostasis, coupled to its
marked modulation in HepG2 cells undergoing ER stress,
prompted us to focus on this molecule. Therefore, the subsequent
experiments were designed to dissect the regulatory mechanisms
underlying hepcidin expression pattern in the presence of an active
UPR.
Although DTT has proven to be a useful UPR inducer [17],
being a reducing agent its spectrum of action is broad and
relatively unspecific. Hence, we hypothesized that DTT could
accelerate Fe
3+ reduction, thereby modulating cellular iron traffic
and, consequently, regulating the expression of the genes under
study [reviewed in 20]. To assess the contribution of iron to the
differential expression of hepcidin in response to DTT, a kinetic
analysis of HepG2 cells exposed to this drug was conducted in the
presence of two distinct iron chelators: desferrioxamine (DFO) and
deferiprone (L1). As displayed in Fig. 3, the 24 h up-regulation of
hepcidin transcripts was preserved in the co-incubation assays,
ruling-out the contribution of chelatable iron to our observations.
As an additional control, BiP and CHOP expression levels were
measured upon 24 h of combined treatment, with no significant
differences found at this point (data not shown).
C/EBPa and CHOP mediate the early down-modulation
of hepcidin upon UPR induction
The liver-enriched nuclear factor C/EBPa has been implicated
in both up- [8] and down- [21] regulation of hepcidin in a variety
of contexts. As a first step to delineate the molecular mechanism(s)
involved in the UPR-dependent modulation of hepcidin expres-
sion, the levels of this transcription factor were evaluated during
the time- and dose-response assays. Western blot analysis of
HepG2 cells exposed to the stressor agents allowed the detection of
two products with the expected sizes of 42 and 30 KDa (Fig. 4A
and B), corresponding to the two C/EBPa isoforms. The lowest
protein levels of C/EBPa (one half the control values) were
observed after 5 h of DTT treatment (Fig. 4A), which coincides
with the decreased expression previously found for hepcidin
(Fig. 2A). Hence, we hypothesized that reduced amounts of C/
EBPa protein might determine a poorer stimulation of the
hepcidin promoter, therefore accounting for the down-modulation
of its transcript levels at this time-point. The mRNA levels of C/
EBPa remained unaffected over the time-course assays (Fig. 4C),
suggesting that the 5 h-repression of this nuclear factor is post-
translationally determined. Since CHOP protein levels also
peaked 5 h post-stimulation with DTT (Fig. 1D), the possibility
of CHOP participating in the modulation of C/EBPa protein
described above was considered. This hypothesis was reinforced
by the dose-response experiments, in which the same range of
DTT concentrations (2–10 mM) accommodated both induction of
CHOP (Fig. 1B) and down-modulation of C/EBPa (Fig. 4B)
proteins. Once again, C/EBPa protein changes did not mirror
those of the correspondent mRNA (Fig. 4D). Employing Hcys as
ER-stress activator, a similar set of results was obtained. In terms
of kinetics, the down-modulation of hepcidin initiated after 5 h of
treatment (Fig. 2B) also overlapped with both induction of CHOP
(Fig. 1D) and reduction of C/EBPa (Fig. 4A) proteins. Overall,
data provided by the dose-response experiments with Hcys (Fig. 1B
and 4D) were in close agreement with the C/EBPa-CHOP
interplay suggested by the DTT assays.
To further test the hypothesis of a C/EBPa protein repression
dependent on CHOP induction we used the DTT model of UPR
activation. HepG2 cells were transfected with siRNA oligonucle-
otides targeting CHOP prior to supplementation of 2 and 5 mM
DTT. Confirming the silencing efficiency, transfection of HepG2
cells with CHOP siRNAs impaired the DTT-stimulation of
CHOP (Fig. 5). Importantly, down-modulation of C/EBPa
protein in response to DTT (2 and 5 mM) was significantly
prevented, thus supporting our initial hypothesis.
Differential C/EBPa binding to hepcidin promoter
mediates the late up-regulation of hepcidin by the UPR
Maintenance of DTT- and Hcys-induced UPR for longer than 5 or
24 h respectively, was accompanied by an up-regulation of hepcidin
expression (Fig. 2A and B). Since this stimulation of hepcidin could not
be directly attributed to quantitative changes in the C/EBPa protein
pool (Fig. 4A), we asked whether in this phase the UPR would be
modulating the binding activity of C/EBPa to the hepcidin promoter.
This question was addressed in vitro by performing a fluorescent variant
of EMSA (fEMSA), in which nuclear extracts of DTT-treated HepG2
cells were combined with a DNA probe containing the consensus
binding sequence recognized by C/EBPa [22]. The single retarded
complex detected was efficiently competed by an excess of unlabeled
UPR and Hepcidin Expression
PLoS ONE | www.plosone.org 3 August 2009 | Volume 4 | Issue 8 | e6618Figure2.Expressionofiron-relatedgenesismodulatedfollowingUPRactivation.HepG2cellswereculturedinthepresenceof2 mMDTT(A)o r
10 mM Hcys (B) for the indicated intervals. Untreated cells were used as control. In dose-response assays, HepG2 cells were treated for 6 h with DTT (C)o r
Hcys (D) at concentrations ranging from 0.5 to10 mM and from 1 to25 mM, respectively.Control cells were incubated with vehicle. After treatments, total
RNA was isolated and mRNA levels of the ‘‘iron-genes’’ hepcidin, ferroportin and ferritin H assessed by real-time RT-PCR. Expression of albumin, a non-iron-
related gene, was evaluated as control in cells subjected to the DTT-induced ER stress. Data were normalized to GAPDH and are expressed as fold change
over control-treated cells. Each bar displays the average+SD of three independent experiments. *p,0.05, **p,0.01, ***p,0.001 vs control.
doi:10.1371/journal.pone.0006618.g002
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an anti-C/EBPa antibody (Fig. 6A, right panel), which attested its
specificity. The intensity of the C/EBPa-DNA complex, reflecting the
binding activity of this nuclear factor to its consensus sequence,
enhanced from 4 to 11 h and returned to baseline values beyond this
time-point (Fig. 6A). Although the kinetics of C/EBPa binding did not
strictly match the expression profile of hepcidin, our fEMSA results
suggest that modulation of C/EBPa binding to hepcidin promoter
might underlie the up-regulation of its expression detected after 24 h of
DTT treatment.
To better examine how DTT affected the binding of C/EBPa
to the hepcidin promoter in vivo, ChIP analysis was carried out. As
Fig. 6B shows, following 24 h of culture in the presence of this ER
stressor, the recruitment of C/EBPa to the hepcidin promoter was
increased, which may account for the up-regulation of hepcidin
mRNA levels detected at the same time-point.
To conclusively confirm the involvement of C/EBPa in the 24 h-
increase of hepcidin transcript levels, a RNA interference approach
was employed. Transfection of HepG2 cells with siRNA oligonu-
cleotides against C/EBPa successfully attenuated the expression of
the corresponding protein (71620% of silencing relative to negative
control siRNA-transfected cells; Fig. 7A). Moreover, C/EBPa
silencing significantly abolished the responsiveness of hepcidin to
the ER-stressor DTT upon 24 h of incubation (Fig. 7B), thus
confirming C/EBPa as a relevant intermediary in the transcrip-
tional regulation of hepcidin by the UPR.
Discussion
Compelling evidence extending the UPR beyond its classical
role in the mitigation of protein misfolding and proteotoxicity has
been provided through its connection to obesity [23] and type 2
diabetes [24], the crosstalk with inflammation [reviewed in 25]
and its impact on the cell surface expression of major
histocompatibility complex (MHC) class I molecules [15,26].
Moreover, previous reports have also suggested the existence of an
interplay between the UPR and iron metabolism [6,9,10]. Details
of this association, however, remain unclear, prompting us to
exploit whether the expression of iron-related genes is influenced
by ER stress-dependent mechanisms.
Hepcidin, a liver-derived peptide hormone, binds to the iron
exporter ferroportin, causing its internalization and degradation,
thereby blocking cellular iron efflux and intestinal iron absorption
[12]. The pivotal role of hepcidin in the maintenance of systemic
iron balance led us to focus on the regulation of its expression in
the context of an active UPR. In our model, mRNA levels of
hepcidin were significantly influenced by the UPR elicited by
Figure 3. Modulation of hepcidin mRNA expression by DTT is
independent of chelatable-iron. HepG2 cells were cultured in the
presence of 2 mM DTT and harvested at the indicated times. For the
iron chelation studies, cells were co-incubated with 20, 50 or 100 mMo f
DFO or L1 per culture plate. As control, cells were exposed to 50 mMo f
each iron chelator alone. After treatments, cDNA was synthesized from
total RNA and mRNA expression levels of hepcidin were quantified by
real-time RT-PCR and normalized to GAPDH. Data are displayed as fold
change over non-treated cells and represent the average+SD of three
independent experiments.
doi:10.1371/journal.pone.0006618.g003
Figure 4. C/EBPa protein but not mRNA levels are modulated by the UPR. HepG2 cells were exposed to 2 mM DTT (A and C) or 10 mM Hcys
(A) for different time periods. Control cells were left untreated. Increasing concentrations of DTT (B and D) or Hcys (B) were used to treat HepG2 cells
during 6 h. Control cells were incubated with vehicle alone. A and B, After cell lysis, C/EBPa protein content was examined in whole extracts by
immunoblot. Two forms of C/EBPa with the expected sizes (42 and 30 KDa) were detected. Molecular weights are indicated in the left side of the
panels. To confirm equal lane loading b-actin was measured. Representative blots of three independent experiments are shown. C and D,
Quantification of C/EBPa mRNA levels in DTT-treated HepG2 cells was performed by real-time RT-PCR. Data were normalized to GAPDH as
endogenous control. Fold change relative to control cells was calculated and is displayed as the average+SD of three independent experiments.
doi:10.1371/journal.pone.0006618.g004
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EBPa as an important mediator of such modulation. Our interest
on this transcription factor was driven by two previous findings: i)
C/EBPa is a liver-enriched nuclear factor known to regulate
hepcidin transcription [8] and ii) C/EBPa can heterodimerize
with other members of the same family, some of which induced by
the UPR signaling program [7]. CHOP is one of these members,
whose higher protein levels consistently overlapped with the down-
modulation of both C/EBPa protein and hepcidin transcripts in
the experimental conditions used. This observation allowed us to
hypothesize a concerted regulation between CHOP and C/EBPa,
successfully supported by the CHOP silencing assays (Fig. 8
depicts a schematic representation of the proposed model).
According to these data, the rise of CHOP levels upon ER stress
leads to a decrease of C/EBPa protein content, which may limit
the availability of this nuclear factor to stimulate hepcidin
transcription, with the concomitant down-modulation of its
mRNA levels. An analogous interplay between C/EBPa and
CHOP was previously described in pre-adipocytes, where CHOP
up-regulation prevented C/EBPa expression [27,28]. Similarly,
the negative regulation of C/EBPa expression by CHOP was
observed in livers from tunicamycin-challenged mice and
proposed as a key mechanism linking ER stress to the disruption
of hepatic lipid metabolism [29].
We found substantial differences in the time-course expression of
the UPR downstream effectors. While increased protein levels of BiP
were sustained, the up-regulation of CHOP was more transient. This
pattern is in agreement with the concept of chronic vs acute stress,
distinguished by detectable levels of BiP or CHOP, respectively [30].
In addition, the loss of CHOP expression is likely on the basis of
hepcidin recovery observed in the long-term incubation with both
stressors. Accordingly, our ChIP analysis revealed that the endoge-
nous hepcidin promoter of HepG2 cells was enriched in the C/EBPa
transcription factor after 24 h of DTT-evoked UPR. One can
speculate that this occurs as an attempt by the cell to compensate for
the deficit of hepcidin expression imposed by CHOP up-regulation.
The modulation of C/EBPa binding activity throughout the ER-
stress response was likewise evidenced by the fEMSA experiments,
although with different kinetics. The discrepancy between the
fEMSA and ChIP data may reflect the inability of the former
method to efficiently mimic binding conditions found in vivo.I tc a n
also be explained by differential affinity of C/EBPa for the binding
sites used in each assay: a C/EBPa consensus binding sequence in
f E M S Aa n dt h en a t i v eC / E B P a-responsive elements within hepcidin
promoter in ChIP.
The contribution of iron to the up-regulation of hepcidin here
reported was excluded when the UPR was chemically elicited by
DTT under iron chelating conditions. Furthermore, it has been
shown that hepatocytes in culture fail to increase hepcidin
production in response to iron loading [31,32].
Our in vitro model system of a pharmacologically-elicited UPR
could render valuable clues when extrapolated to a physiological
context. Hepcidin levels are known to be abnormally low in HFE-
linked Hereditary Hemochromatosis (HH) [13]. Considering that
markers of an active UPR were formerly found in individuals
homozygous for the C282Y mutation of HFE [15], it is tempting
to speculate that the CHOP-C/EBPa interconnection here
described may contribute to the impaired induction of hepcidin
expression regardless of the iron burden. The intersection between
the UPR signaling pathways and the transcriptional regulation of
hepcidin could therefore contribute to explaining some of the
phenotypic variation amongst HH patients [33].
Regarding the other two genes examined in the present study, up-
regulation of ferroportin and ferritin H was found in HepG2
following the UPR activation, both in dose- and time-response assays.
Although beyond the scope of this work, some hypotheses can be
drawn concerning the molecular pathways involved in such outcome
(summarized in Fig. 8). Apart from the supra-mentioned post-
translational regulation by hepcidin [12], expression of ferroportin is
also controlled by a well established Iron Responsive Element (IRE)/
Iron Regulatory Protein (IRP) mechanism [34]. Nonetheless,
elevated hepatic mRNA levels of ferroportin were detected in HFE
C282Y homozygous despite iron overload [13,35], thus suggesting
that transcriptional events also contribute to itsregulation[36]. Inline
with this, in silico analysis of ferroportin gene and promoter showed
the presence of a number of putative binding sites for transcription
factors commonly induced during the UPR (e.g. ATF/CRE, AARE,
CHOP-binding sequence; http://www.genomatix.de). Hence, we
reasoned that the presence of such regulatory elements might confer
some UPR-responsiveness to ferroportin.
Ferritin is an iron-storage protein whose regulation also depends
on the IRE/IRP post-transcriptional system [37]. Interestingly, the
existence of an antioxidant-responsive element (ARE) activated
Figure 5. Reduction of C/EBPa protein levels depends on CHOP
up-regulation. HepG2 cells were transfected with CHOP or scrambled
(Neg) siRNAs for 24 h or left untreated (No DNA). DTT was added at the
indicated dosage in the last 6 h of the transfection period. Efficacy of
CHOP silencing was assessed in total cell lysates by western blot with
anti-CHOP antibody (upper panel). Blots were also probed to C/EBPa
and the two expected products (42 and 30 KDa) were detected (middle
panel). b-actin was employed as loading control. The intensity of bands
relative to CHOP and the 42 KDa-form of C/EBPa was quantified by
densitometry, normalized to b-actin and graphically represented as
average+SD of three independent experiments. *p,0.05.
doi:10.1371/journal.pone.0006618.g005
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program [38], was reported for the H- and L- isoformsof ferritin gene
[39]. Taken together, this report and our experimental data are
indicative of a complementary/additive action driven by both iron
excess and UPR activation towards ferritin mRNA up-regulation.
The boost of ferroportin and ferritin H can be envisaged as a
mechanism to prevent intracellular accumulation of free iron. Our data
of albumin expression seem to exclude a mere UPR-‘‘side effect’’ as the
reason behind our observations, supporting the likelihood of their
physiological relevance. Whether the modulation of iron-related genes
is part of a general UPR strategy aiming at maintaining cell viability
andhomeostasisor,instead,it representsa novelpathwayto specifically
control the expression of a subset of genes related to iron metabolism,
remains the subject for further study.
Materials and Methods
Cell culture
Human hepatoma HepG2 cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) with GlutaMAX (Gibco,
Grand Island, NY), supplemented with 10% heat-inactivated fetal
bovine serum (Gibco, Grand Island, NY) and 1% penicillin/
streptomycin/amphotericin (Sigma, St. Louis, MO). Cells were
cultured at 37uC in a humidified atmosphere containing 5% CO2.
Induction of ER stress and iron chelation
HepG2 cells were seeded at a density of 1.5610
6 cells in 60-mm
diameter culture dishes. One day after plating, cells were exposed
to dithiothreitol (DTT; Sigma-Aldrich, St. Louis, MO) or
homocysteine (Hcys; Sigma-Aldrich, St. Louis, MO) as follows:
1) for dose-response assays, cells were incubated for 6 h with
increasing concentrations of the ER-stressors (ranging from 0.5–
10 mM or 1–25 mM for DTT and Hcys, respectively); 2) for time-
course experiments, cells were cultured in the presence of 2 mM
DTT from 2–24 h or 10 mM Hcys from 2–48 h. Control cells
were treated with vehicle alone. Stock solutions of DTT and Hcys
were prepared and frozen as single-use aliquots to maintain
consistency among experiments. In the iron chelation experiments,
DTT-stimulated ER stress was induced in the presence of either
desferrioxamine (DFO; Novartis Pharma) or deferiprone (L1;
Figure 6. DNA-binding activity of C/EBPa is modulated over the time-course of UPR activation. HepG2 cells cultured in the presence of
2 mM DTT for the indicated intervals were subjected to fEMSA (A) and ChIP (B) analyses. A, Nuclear protein extracts from DTT- or control-treated cells
were combined with the Cy5-labeled specific probe containing the C/EBPa consensus binding site (C/EBPa SP) and electrophoresed under native
conditions. For competition assays, a 50-fold molar excess of unlabeled probe (C/EBPa SC) was used (lanes 4 and 6). The specific DNA-protein
complex is indicated by an arrow. Free-probe is also shown in the bottom of the gel. The fEMSA gel view displayed is representative of four
independent experiments (left panel). A specific antibody against C/EBPa was added for the supershift reaction (right panel). The partial shift is
highlighted in the right side of the figure. B, Cross-linked chromatin was immunoprecipitated with anti-C/EBPa or anti-IgG (serum control) antibodies.
The recovered chromatin samples were analyzed by quantitative real-time PCR with primers flanking the C/EBPa binding site found within the 2136/
+9 region of human HAMP promoter. Results depict the enrichment relative to serum control immunoprecipitation normalized to ChIP input values
and are expressed as average+SD of three independent experiments.
doi:10.1371/journal.pone.0006618.g006
UPR and Hepcidin Expression
PLoS ONE | www.plosone.org 7 August 2009 | Volume 4 | Issue 8 | e6618Sigma-Aldrich, St. Louis, MO) at 20, 50 or 100 mM per culture
plate. mRNA levels of target genes were assessed in cells exposed
to both DTT and iron chelators following 24 h of incubation.
RNA isolation and real-time RT-PCR
Total RNA was isolated from HepG2 cells using the RNeasy Midi
Kit (QIAGEN, Hilden, Germany), followed by genomic DNA
digestion with TURBO DNA-free (Ambion, Austin, TX). Reverse
transcription was obtained from 1 mg of DNase-treated RNA
employing the SuperScript First-Strand Synthesis System (Invitrogen,
Carlsbad, CA), according to the manufacturer’s guidelines. For real-
time quantification of mRNA levels, the synthesized cDNA’s were
amplified in duplicate by PCR in an iCycler iQ5 (Bio-Rad, Hercules,
CA) using iQ SYBR Green Supermix (Bio-Rad, Hercules, CA). At the
end of the PCR cycling, melting curves were generated to ascertain the
amplification of a single product and the absence of primer dimers. All
the primers used are listed in Table 1. Results were normalized to
GAPDH as endogenous control. Relative expression levels were
calculated as follows: 2 Ct GAPDH gene{Ct gene of interest ðÞ |1000:
Antibodies and Western blot
Mouse anti-KDEL and rabbit anti-b-actin antibodies were
purchased from Abcam (Cambridge, UK). Goat anti-C/EBPa
(C-18) and rabbit anti-GADD153 (R-20) antibodies were supplied
by Santa Cruz Biotechnology (Santa Cruz, CA). Following
treatment with the ER stressors, HepG2 cells were harvested and
thepelletslysedinice-coldlysisbuffer (300 mMNaCl,50 mMTris-
HCl pH 7.4, 1% Triton X-100) supplemented with 1x Complete
EDTA-free protease inhibitor cocktail (Roche Diagnostics, Man-
nheim, Germany). Total protein content of lysates was measured
using the RC/DC Protein Assay (Bio-Rad, Hercules, CA) and 30 mg
resolved by electrophoresis on 12% SDS-polyacrylamide gels.
Proteins were then transferred to nitrocellulose Hybond-C Extra
membranes (Amersham Biosciences, Little Chalfont, UK). After
blocking with 5% dry milk in Tris-buffered saline containing 0.05%
Tween 20 (TBS-T) for 1 h, primary antibody incubations were
performed overnight at 4uC. Blots were then washed three times
with TBS-T and incubated with appropriate horseradish peroxi-
dase-conjugated secondary antibodies (Molecular Probes, Eugene,
OR)for1 h atroomtemperature.AfterwashingwithTBS-T,signal
was developed with the SuperSignal West Pico (Pierce, Rockford,
IL) chemiluminescence kit and the blots exposed to CL-X Posure
films (Pierce, Rockford, IL). For normalization of protein loading,
blots were stripped and reprobed with an antibody against b-actin.
Preparation of nuclear extracts and Electrophoretic
Mobility Shift Assay (EMSA)
Nuclear extracts from DTT- and control-treated cells were prepared
essentially as described by Schreiber et al. [40]. Briefly, after harvesting
and washing with ice-cold PBS, cells were suspended in hypotonic
buffer (10 mM HEPES pH 7.9, 1.5 mM MgCl2,1 0 m MK C l ,
0.5 mM EDTA, 0.1 mM EGTA, 0.1% IGEPAL, 1 mM DTT, 1x
Complete EDTA-free protease inhibitor cocktail [Roche Diagnostics]).
Upon 15 min of incubation on ice, the nuclei were pelleted by
centrifugation at 2000 gfor 10 min and resuspended in high-salt buffer
(20 mM HEPES pH 7.9, 1.5 mM MgCl2, 20% glycerol, 0.5 mM
EDTA, 420 mM NaCl, 1 mM DTT, 1x Complete EDTA-free
protease inhibitor cocktail [Roche Diagnostics]). Following incubation
Figure 7. Silencing of C/EBPa partially prevents the late increase of hepcidin induced by the UPR. HepG2 cells were transfected with C/
EBPa or scrambled (Neg) siRNAs for 48 h or left untreated (No DNA). Cells were exposed to DTT during the last 24 h of transfection procedure. A,
Efficiency of C/EBPa knock-down was evaluated in whole cell extracts by western blot using an antibody against C/EBPa. The typical 42 and 30 KDa
products were detected. To equalize lane loading b-actin was probed. A representative blot is shown. Intensity of the 42 KDa-band of C/EBPa was
quantified by densitometry, normalized to b-actin and plotted as average+SD of three independent experiments. B, Total RNA of siRNA-transfected or
untreated (No DNA) HepG2 was isolated. Using real-time RT-PCR, mRNA expression levels of hepcidin were measured and normalized to the GAPDH
house-keeping gene. Data are expressed as fold change over No DNA-treated cells. *p,0.05, ***p,0.001.
doi:10.1371/journal.pone.0006618.g007
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by centrifugation at 16000 gfor 25 min and the nuclear extract present
on supernatants stored at 280uC. To investigate specific DNA-protein
interactions, a fluorescence based EMSA was employed according to
previously reported procedures [41]. The following single-stranded
oligonucleotides encompassing the C/EBPa consensus sequence
element [22] were purchase from Thermo Scientific (Waltham,
MA): 59-Cy5-CTAGGGCTTGCGCAATCTATATTCG-39 (Cy5-
labeled sense specific probe), 59-CTAGGGCTTGCGCAATCTA-
TATTCG-39 (sense specific competitor) and 59-CGAATATA-
GATTGCGCAAGCCCTAG-39 as antisense complementary oligo-
nucleotide. To generate double-stranded probes for EMSA, single
Figure 8. Schematic overview of the mechanisms underlying the UPR-induced modulation of iron-related genes. Activation of the
PERK-dependent branch of the UPR modulates CHOP levels. This will in turn affect the C/EBPa protein pool and ultimately the stimulation of the
hepcidin (HAMP) promoter. Regarding the other iron-genes, both ferritin H (FTH1) and ferroportin (FPN) display putative binding sites recognized by
transcription factors (TFs) activated during the UPR. The presence of these regulatory elements may confer some UPR-responsiveness to ferritin H and
ferroportin, increasing their expression in response to ER stress.
doi:10.1371/journal.pone.0006618.g008
Table 1. Sequences of the oligonucleotide primers used for quantitative real-time RT-PCR analysis.
Gene Accession number Protein coded Forward primer (59–39) Reverse Primer (59–39)
GRP78 M19645 BiP CCTGGGTGGCGGAACCTTCGATGTG CTGGACGGGCTTCATAGTAGACCGG
GADD153 S40706 CHOP GCCTTTCTCCTTTGGGACACTGTCCAGC CTCGGCGAGTCGCCTCTACTTCCC
HAMP NM_021175 Hepcidin ATGGCACTGAGCTCCCAGAT TTCTACGTCTTGCAGCACATCC
CEBPA NM_004364 C/EBPa CTAGAGATCTGGCTGTGGGG TCATAACTCCGGTCCCTCTG
SLC40A1 NM_014585 Ferroportin CCCGGAGACAAGTCCTGAATC TGGCCCATTGCCACAAAGGAG
FTH1 AF088851 Ferritin H CAGAACTACCACCAGGACTCAGA TAGCCCGAGGCTTAGCTTTCA
ALB NM_000477 Albumin CAAAAACATGTGTTGCTGATGA CTTGTTTTGCACAGCAGTCAG
GAPDH NM_002046 GADPH GAAGGTGAAGGTCGGAGTC GAAGATGGTGATGGGATTTC
doi:10.1371/journal.pone.0006618.t001
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followed by 30 min at 20uC. For binding reactions, 20 mgo fn u c l e a r
extract was incubated with 1 pmol of double-stranded Cy5-labeled
probe in binding buffer containing 20 mM HEPES pH 7.9, 50 mM
K C l ,1 m ME D T A ,1 m MD T T ,1 0 %g l y c e r o la n d2 5 0 n g
poly[dI.dC] (Sigma, St. Louis, MO). Binding reactions were carried
out overnight at 4uC and then subjected to electrophoresis through 5%
nondenaturing polyacrylamide gels using an ALF-Express DNA
sequencer (Amersham Pharmacia Biotech, Uppsala, Sweden). The
temperature was maintained at 10uCb ya nA L F e x p r e s sI IC o o l e r
external thermostat (Amersham Pharmacia Biotech, Uppsala, Swe-
den). Signals were analyzed using ALFwin 1.03 software (Amersham
Pharmacia Biotech). For the competition assays, 50-fold excess
unlabeled probe was added to the reaction 1 h prior to incorporation
of the labeled duplex. For supershift experiments, nuclear extracts were
pre-incubated overnight at 4uCw i t h2mL of antibody against C/
EBPa (C-18X; Santa Cruz Biotechnology, Santa Cruz, CA) and the
labelled probe added 1 h before the loading onto the gel.
Chromatin Immunoprecipitation (ChIP)
HepG2 cells were grown in 100-mm diameter culture dishes to
,70% of confluence and subjected to time-course assays with
2 mM DTT as depicted above. ChIP analysis was performed as
previously described by Kuo et al. [42] with some modifications.
Cells were cross-linked in 1% formaldehyde (directly added to the
culture medium) for 10 min at 37uC. After washing twice with
cold PBS, cells were scraped and lysed in SDS lysis buffer (1%
SDS, 10 mM EDTA, 50 mM Tris-HCl pH 8.1) supplemented
with 1x Complete EDTA-free protease inhibitor cocktail for
30 min on ice. Chromatin was shared into 500–1000 bp size
fragments by sonicating the cell lysates with a Branson Sonifier
250 (10 cycles of 20 sec at 30% amplitude). After removing cell
debris by centrifugation at 14000 g for 10 min, an aliquot of the
supernatant was saved as input DNA. The remainder was 10-fold
diluted in ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100,
1.2 mM EDTA, 16.7 mM Tris-HCl pH 8.1, 167 mM NaCl) and
pre-cleared with Protein A Sepharose beads (Sigma-Aldrich, St.
Louis, MO) during 2 h at 4uC. Immunoprecipitation of chromatin
was carried out overnight at 4uC using rabbit anti-C/EBPa
antibody (14AA; Santa Cruz Biotechnology) or rabbit anti-IgG
(Santa Cruz Biotechnology) as serum control. Immune complexes
were recovered with Protein A Sepharose beads for 2 h at 4uC.
The beads were then washed sequentially with: a) Low-salt buffer
(0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl
pH 8.1, 150 mM NaCl); b) High-salt buffer (as previous but with
500 mM NaCl); c) LiCl buffer (0.25 M LiCl, 1% NP-40, 1%
deoxycholic acid, 1mM EDTA, 10 mM Tris-HCl pH 8.1) and d)
TE buffer (1 mM EDTA, 10 mM Tris-HCl pH 8.1). The immune
complexes were eluted with elution buffer (1% SDS, 0.1 M
NaHCO3) and protein-DNA crosslinks reversed for 6 h at 65uCi n
the presence of 0.2 M NaCl. Following Proteinase K (Sigma-
Aldrich, St. Louis, MO) digestion for 1 h at 45uC, DNA was
extracted with phenol/chloroform, ethanol precipitated and
dissolved in TE buffer containing RNase H. The chromatin
fragments obtained upon immunoprecipitation were analyzed by
quantitative real-time PCR, using 5 mL of DNA template, iQ
SYBR Green Supermix and the primers as follows: 59-
TGTCGCTCTGTTCCCGCTTATC-39 (forward) and 59-
TCTGGTGTCTGGGACCGAGTGA-39 (reverse). This primer
set was designed to amplify the 2136/+9 region of human HAMP
promoter that contains a literature-annotated C/EBPa binding
site [8]. The relative enrichment was calculated by the DDCt
method: upon normalization to the corresponding ChIP input,
values were corrected for non-immune background according to
the equation as follows 2(Ct neg IP - Ct input) - (Ct C=EBPa IP- Ctinput):
siRNA transfection
Small interfering RNA’s (siRNA’s) targeting human C/EBPa
and CHOP were designed and synthesized by Eurogentec (Ougre ´e,
Belgium). The siRNA sequences were as follows: C/EBPa (59-
CGCACCUGCAGUUCCAGAU-39 and 59-GAGACGUCCAU-
CGACAUCA-39); CHOP (59- GCGCAUGAAGGAGAAAGAA-
39 and 59-GCUGAGUCAUUGCCUUUCU-39). A scrambled
siRNA (Eurogentec) was used as negative control. To improve the
transfection efficiency, a cell-suspension variant of the standard
protocol was applied to HepG2 cells. Briefly, after trypsinization
and dilution in antibiotic-free medium, 3610
5 cells were transferred
to 6-well plates containing the siRNA duplexes complexed with
Lipofetamine2000 (Invitrogen, Carlsbad, CA), previously diluted in
Opti-MEM (Gibco, Grand Island, NY). Following 48 or 24 h of
transfection, for C/EBPa or CHOP respectively, the knock-down
effectiveness was evaluated by immunoblot analysis.
Statistics
Results are expressed as average+standard deviation (SD) of
three independent experiments. To detect significant differences
among sample means, one-way ANOVA repeated measurements,
followed by Tukey test was used. Statistical significance was
considered at p,0.05. Statistical analysis was performed using
SigmaStat software.
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